MedPath

Uremic Toxin Removal With a New High Flux Cellulose Triacetate Membrane

Not Applicable
Completed
Conditions
Haemodialysis
Registration Number
NCT00230906
Lead Sponsor
University Hospital, Ghent
Brief Summary

Comparison of the uremic toxin removal by haemodialysis either with a low flux or a new high flux cellulose triacetate membrane

Detailed Description

Comparison of the uremic toxin removal by haemodialysis either with a low flux or a new high flux cellulose triacetate membrane

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
12
Inclusion Criteria
  • Chronic haemodialysis patient
  • Serum albumin > 3.6 g/dl
Exclusion Criteria
  • < 18 years

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Concentration of uremic components after 3 weeks of haemodialysis
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University Hospital Ghent

🇧🇪

Ghent, Belgium

© Copyright 2025. All Rights Reserved by MedPath